Stable Isotope Kinetic Study of ApoM (Apolipoprotein M)

Archive ouverte

Croyal, Mikaël | Billon-Crossouard, Stéphanie | Goulitquer, Sophie | Aguesse, Audrey | León, Luis | Fall, Fanta | Chetiveaux, Maud | Moyon, Thomas | Blanchard, Valentin | Ouguerram, Khadija | Lambert, Gilles | Nobecourt, Estelle | Krempf, Michel

Edité par CCSD ; American Heart Association -

Clinical and population studies. International audience. Objective—ApoM (apolipoprotein M) binds primarily to high-density lipoprotein before to be exchanged with apoB (apolipoprotein B)-containing lipoproteins. Low-density lipoprotein (LDL) receptor-mediated clearance of apoB-containing particles could influence plasma apoM kinetics and decrease its antiatherogenic properties. In humans, we aimed to describe the interaction of apoM kinetics with other components of lipid metabolism to better define its potential benefit on atherosclerosis. Approach and Results—Fourteen male subjects received a primed infusion of H-2(3)-leucine for 14 hours, and analyses were performed by liquid chromatography-tandem mass spectrometry from the hourly plasma samples. Fractional catabolic rates and production rates within lipoproteins were calculated using compartmental models. ApoM was found not only in high-density lipoprotein (59%) and LDL (4%) but also in a non-lipoprotein-related compartment (37%). The apoM distribution was heterogeneous within LDL and non-lipoprotein-related compartments according to plasma triglycerides (r=0.86; P<0.001). The relationships between sphingosine-1-phosphate and apoM were confirmed in all compartments (r range, 0.55-0.89; P<0.05). ApoM fractional catabolic rates and production rates were 0.16 +/- 0.07 pool/d and 0.14 +/- 0.06 mg/kg per day in high-density lipoprotein and 0.56 +/- 0.10 pool/d and 0.03 +/- 0.01 mg/kg per day in LDL, respectively. Fractional catabolic rates of LDL-apoM and LDL-apoB100 were correlated (r=0.55; P=0.042). Significant correlations were found between triglycerides and production rates of LDL-apoM (r=0.73; P<0.004). Conclusions—In humans, LDL kinetics play a key role in apoM turnover. Plasma triglycerides act on both apoM and sphingosine-1-phosphate distributions between lipoproteins. These results confirmed that apoM could be bound to high-density lipoprotein after secretion and then quickly exchanged with a non-lipoprotein-related compartment and to LDL to be slowly catabolized.

Consulter en ligne

Suggestions

Du même auteur

VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly

Archive ouverte | Croyal, Mikaël | CCSD

International audience. OBJECTIVE: To clarify the association between PCSK9 (proprotein convertase subtilisin/kexin type 9) and Lp(a) (Lipoprotein [a]), we studied Lp(a) kinetics in patients with loss-of-function an...

Fenofibrate decreases plasma ceramides in type 2 diabetic patients: a novel marker for CVD?

Archive ouverte | Croyal, Mikael | CCSD

International audience. AimThe benefit of the lipid-lowering drug fenofibrate on cardiovascular outcomes is controversial. Our aim was to find new circulating markers to identify those patients most likely to benefi...

Plasma PCSK9 measurement by liquid chromatography-Tandem mass spectrometry and comparison with conventional ELISA

Archive ouverte | Croyal, Mickael | CCSD

The combination of liquid chromatography-tandem mass spectrometry (LC-MS/MS) and trypsin proteolysis is an effective tool for accurate quantitation of multiple proteins in a single run. However, expensive samples pre-treatment as ...

Chargement des enrichissements...